Comparative study of disc diffusion and microdilution methods in susceptibility testing of micafungin against Candida species

Journal of Antimicrobial Chemotherapy

Volumn 58, Issue 4, 2006, Pages 861-863

  Ramirez M ^a   Serrano, M C ^a   Castro, C ^a   Lopez E ^a   Almeida, C ^a   Fernandez A ^a   Romero, A ^a   Martín Mazuelos, Estrella ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

Antifungals; Lipopeptides; Susceptibility testing

Indexed keywords

MICAFUNGIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSION; DILUTION; FUNGAL STRAIN; FUNGUS GROWTH; GROWTH INHIBITION; HUMAN; INCUBATION TEMPERATURE; INCUBATION TIME; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRACTICE GUIDELINE;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS, ORAL; CULTURE MEDIA; DRUG RESISTANCE, FUNGAL; HIV INFECTIONS; HUMANS; LIPOPROTEINS; MICROBIAL SENSITIVITY TESTS; PEPTIDES, CYCLIC;

EID: 33748698627     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl335     Document Type: Article

References (10)

1. Edmond MB, Wallace SE, McClish DK et al. Nosocomial bloodstream infections in United States hospital: A three-year analysis. Clin Infect Dis 1999; 29: 239-44.
2. Rubio Calvo MC, Gil J, Ramírez de Ocáriz I et al. Actividad in vitro de fluconazol, voriconazol y posaconazol frente a Candida spp. Rev Esp Quimioterap 2003; 16: 227-32.
3. Cuenca-Estrella M, Mellado E, Diaz-Guerra TM et al. Susceptibility of fluconazole-resistant clinical isolates of Candida spp to echinocandin LY303366, itraconazole and amphotericin. Antimicrob Agents Chemother 2000; 41: 1835-6.
4. Denning DW. Echinocandins and pneumocandins a new antifungal class with a novel mode of action. J Antimicrob Chemother 1997; 40: 611-4.
5. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved standard M27-A2. NCCLS, Wayne, PA, USA, 2002.
6. Lozano-Chiu M, Page WN, Victor LP et al. Disk diffusion method for determining susceptibilities of Candida spp. to MK-0991. J Clin Microbiol 1999; 37: 1625-7.
7. Espinel-Ingroff A, Montero D, Martin-Mazuelos E. Long-term preservation of fungal isolates in commercially prepared cryogenic microbank vials. J Clin Microbiol 2004; 42: 1257-9.
8. Pfaller MA, Messer SA, Boyken L et al. Further standardization of broth microdilution methodology for in vitro susceptibility testing of caspofungin against Candida species by use of an international collection of more than 3,000 clinical isolates. J Clin Microbiol 2004; 42: 3117-19.
9. National Committee for Clinical Laboratory Standards. Method for Antifungal Disc Diffusion Susceptibility Testing of Yeasts: Propose Guideline M44-A. NCCLS Wayne, PA, USA, 2004.
10. Stevens DA, Espiritu M, Parmar R. Paradoxical Effect of caspofungin: reduced activity against Candida albicans at high drug concentration. Antimicrob Agents Chemother 2004; 48: 3407-11.